No safety concerns with Rotarix concludes EMA

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1295-1296, 2010-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety updates from EMA's CHMP

By  

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

EMA reviews Ixiaro following recall, annuls potency concerns

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Health Canada concludes from a recent safety review that hepatotoxicity remains an important safety concern for patients using antiandrogens.

By  

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Significant safety concerns with doripenem

By  

Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

ISMP highlights safety concerns for varenicline

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite